Publication Name	World Journal of Gastroenterology
Manuscript ID	90154
Country	China

Received	2023-11-25 05:23
Peer-Review Started	2023-11-25 05:25
To Make the First Decision
Return for Revision	2024-02-08 03:43
Revised	2024-02-14 07:17
Second Decision	2024-04-01 01:39
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-04-01 01:54
Articles in Press	2024-04-01 01:54
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-04-22 00:38
Publish the Manuscript Online	2024-04-26 08:53

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Editorial
Article Title	Fecal microbiota transplantation for irritable bowel syndrome: Current evidence and perspectives
Manuscript Source	Invited Manuscript
All Author List	Cong Dai, Yu-Hong Huang and Min Jiang
ORCID	Author(s) ORCID Number Cong Dai http://orcid.org/0000-0003-1317-183X Yu-Hong Huang http://orcid.org/0000-0001-6228-3022 Min Jiang http://orcid.org/0000-0003-0533-7000
Funding Agency and Grant Number
Corresponding Author	Min Jiang, Doctor, PhD, Professor, Department of Gastroenterology, First Hospital of China Medical University, No. 92 of Beier Road, Heping District, Shenyang 110001, Liaoning Province, China. congdai2006@126.com
Key Words	Fecal microbiota transplantation; Irritable bowel syndrome; Microbiota; Randomized controlled trial; Meta-analysis
Core Tip	Fecal microbiota transplantation (FMT) has emerged as a efficacious intervention for Clostridium difficile infection and holds promise as a therapeutic modality for irritable bowel syndrome (IBS). The utilization of FMT in the treatment of IBS has undergone scrutiny in numerous randomized controlled trials, yielding divergent outcomes. The current frontier in this field seeks to elucidate these variations, underscore the existing knowledge gaps that necessitate exploration, and provide a guideline for successful FMT implementation in IBS patients. At the same time, the application of FMT as a treatment for IBS confronts several challenges.
Publish Date	2024-04-26 08:53
Citation	Dai C, Huang YH, Jiang M. Fecal microbiota transplantation for irritable bowel syndrome: Current evidence and perspectives. World J Gastroenterol 2024; 30(16): 2179-2183
URL	https://www.wjgnet.com/1007-9327/full/v30/i16/2179.htm
DOI	https://dx.doi.org/10.3748/wjg.v30.i16.2179

Full Article (PDF)	WJG-30-2179-with-cover.pdf
Manuscript File	90154_Auto_Edited-YJP.docx
Answering Reviewers	90154-Answering reviewers.pdf
Audio Core Tip	90154-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	90154-Conflict-of-interest statement.pdf
Copyright License Agreement	90154-Copyright license agreement.pdf
Peer-review Report	90154-Peer-review(s).pdf
Scientific Misconduct Check	90154-Bing-Qu XL-2.jpg
Scientific Editor Work List	90154-Scientific editor work list.pdf
CrossCheck Report	90154-CrossCheck report.pdf